These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 25190190

  • 1. Alterations in collagen and mineral nanostructure observed in osteoporosis and pharmaceutical treatments using simultaneous small- and wide-angle X-ray scattering.
    Acerbo AS, Kwaczala AT, Yang L, Judex S, Miller LM.
    Calcif Tissue Int; 2014 Nov; 95(5):446-56. PubMed ID: 25190190
    [Abstract] [Full Text] [Related]

  • 2. Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study.
    Fratzl P, Schreiber S, Roschger P, Lafage MH, Rodan G, Klaushofer K.
    J Bone Miner Res; 1996 Feb; 11(2):248-53. PubMed ID: 8822349
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in intracortical microporosities induced by pharmaceutical treatment of osteoporosis as detected by high resolution micro-CT.
    Tommasini SM, Trinward A, Acerbo AS, De Carlo F, Miller LM, Judex S.
    Bone; 2012 Mar; 50(3):596-604. PubMed ID: 22226688
    [Abstract] [Full Text] [Related]

  • 5. Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits.
    Vrahnas C, Buenzli PR, Pearson TA, Pennypacker BL, Tobin MJ, Bambery KR, Duong LT, Sims NA.
    Calcif Tissue Int; 2018 Dec; 103(6):625-637. PubMed ID: 30019315
    [Abstract] [Full Text] [Related]

  • 6. Characterising bone material composition and structure in the ovariectomized (OVX) rat model of osteoporosis.
    Mathavan N, Turunen MJ, Tägil M, Isaksson H.
    Calcif Tissue Int; 2015 Aug; 97(2):134-44. PubMed ID: 25894067
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effects of synthetic salmon calcitonin and alendronate on bone quality in ovariectomized rats].
    Giardino R, Fini M, Nicoli Aldini N, Gnudi S, Biagini G, Gandolfi MG, Mongiorgi R.
    Minerva Med; 1997 Nov; 88(11):469-77. PubMed ID: 9454099
    [Abstract] [Full Text] [Related]

  • 10. Effect of administration of alendronate sodium and retinol on the mechanical properties of the femur in ovariectomized rats.
    Sliwiński L, Janiec W, Pytlik M, Folwarczna J, Kaczmarczyk-Sedlak I, Pytlik W, Cegieła U, Nowińska B.
    Pol J Pharmacol; 2004 Nov; 56(6):817-24. PubMed ID: 15662095
    [Abstract] [Full Text] [Related]

  • 11. Bone remodeling after administration of proton pump (H+/K+-ATPase) inhibitors and alendronate in ovariectomized rats.
    Pytlik M, Cegieła U, Nowińska B, Folwarczna J, Sliwiński L, Kaczmarczyk-Sedlak I, Pytlik M, Bolek D, Korzeniowska H.
    Acta Pol Pharm; 2012 Nov; 69(1):113-20. PubMed ID: 22574514
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of rosiglitazone on bone mass and fragility is reversible and can be attenuated with alendronate.
    Kumar S, Hoffman SJ, Samadfam R, Mansell P, Jolette J, Smith SY, Guldberg RE, Fitzpatrick LA.
    J Bone Miner Res; 2013 Jul; 28(7):1653-65. PubMed ID: 23456892
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
    Feher A, Koivunemi A, Koivunemi M, Fuchs RK, Burr DB, Phipps RJ, Reinwald S, Allen MR.
    Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
    [Abstract] [Full Text] [Related]

  • 17. Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs.
    Roschger P, Fratzl P, Klaushofer K, Rodan G.
    Bone; 1997 May; 20(5):393-7. PubMed ID: 9145235
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE, Stavropoulou A, Anastassopoulos G, Panteliou SD, Papadaki E, Karamanos NK, Panagiotopoulos E.
    J Pharm Biomed Anal; 2006 Jun 07; 41(3):891-7. PubMed ID: 16488571
    [Abstract] [Full Text] [Related]

  • 19. Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate.
    Gamsjaeger S, Buchinger B, Zoehrer R, Phipps R, Klaushofer K, Paschalis EP.
    Bone; 2011 Dec 07; 49(6):1160-5. PubMed ID: 21893225
    [Abstract] [Full Text] [Related]

  • 20. Raman spectroscopy as a predictive tool for monitoring osteoporosis therapy in a rat model of postmenopausal osteoporosis.
    Beattie JR, Sophocleous A, Caraher MC, O'Driscoll O, Cummins NM, Bell SEJ, Towler M, Rahimnejad Yazdi A, Ralston SH, Idris AI.
    J Mater Sci Mater Med; 2019 Feb 12; 30(2):25. PubMed ID: 30747334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.